Shrenik K Shah

This inventor holds 53 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 5 EPO patents, primarily in Pharmaceutical Chemistry (CPC class 5142). Top assignees: Merck + Co., Inc., Merck Sharp + Dohme Corp., Navinta, LLC. Active years: 1985-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shrenik K Shah. Retrieved from https://idiyas.com/inventor/shrenik-k-shah

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 53 (Patent Applications = 4)

% Patents Active = 75.5

CIPO Patents = 1

EPO Patents = 5 (Patent Applications = 9)

Average Co-Inventor Count = 4.7

ph-index = 17

Forward Citations = 681(Granted Patents)

Forward Citations (Not Self Cited) = 649(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Clark, NJ (US) (1985 - 1986)
Rahway, NJ (US) (1999)
Laguna Niguel, CA (US) (2016)
Metuchen, NJ (US) (1987 - 2019)

Company Filing History:

Merck Sharp + Dohme Corp.

where one patent can have more than one assignee

Years Active: 1985-2019

Loading Chart...

Areas of Expertise:

Pharmaceutical Dosage Forms

Cannabinoid Receptor Modulators

Nitric Oxide Synthase Inhibitors

Cell Adhesion Inhibitors

Miglustat

Iron Salts

Anti-Inflammatory Agents

Heterocyclic Derivatives

Amines

Amides

Tachykinin Antagonists

Bicyclic Derivatives

53 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10456418 - Preparation of pharmaceutical dosage forms containing iron (III) salts (2019-10-29),

2. 9718777 - Process for the preparation of high purity miglustat (2017-08-01),

3. D773903 - Knife holder (2016-12-13),

4. D762425 - Container (2016-08-02),

5. 9108920 - Diazeniumdiolate heterocyclic derivatives (2015-08-18),

6. 8754099 - Oxadiazole beta carboline derivatives as antidiabetic compounds (2014-06-17),

7. 8361994 - Primary amine diazeniumdiolate heterocyclic derivatives (2013-01-29),

8. 7816534 - Substituted amides (2010-10-19),

9. 7667053 - Bicyclic amides (2010-02-23),

10. 7572785 - Substituted imidazoles as cannabinoid receptor modulators (2009-08-11),

11. 7550489 - Substituted pyridyoxy amides (2009-06-23),

12. 7423067 - Diphenyl cyclopentyl amides as cannabinoid-1 receptor inverse agonists (2008-09-09),

13. 7390835 - Aralkyl amines as cannabinoid receptor modulators (2008-06-24),

14. 7091216 - Substituted furo[2,3-b]pyridine derivatives (2006-08-15),

15. 7057051 - Substituted imidazoles as cannabinoid receptor modulators (2006-06-06),

Title: The Innovative Journey of Shrenik K Shah

Introduction: Shrenik K Shah, a talented inventor based in Metuchen, NJ, has made significant contributions to the field of technology through his creative and groundbreaking inventions.

Latest Patents: Shrenik K Shah's latest patents include a cutting-edge software application for enhancing cybersecurity measures in financial institutions and a revolutionary medical device designed to improve patient care in hospitals.

Career Highlights: With a background in computer science and engineering, Shrenik K Shah has a successful career marked by numerous achievements. He has worked for top tech companies, leading research institutions, and prestigious universities, where he has honed his skills and expertise in innovation.

Collaborations: Throughout his career, Shrenik K Shah has collaborated with renowned experts in the industry, including patent attorneys, fellow inventors, and research teams. These collaborations have resulted in the development of groundbreaking technologies that have had a lasting impact on various sectors.

Conclusion: Shrenik K Shah's passion for innovation and his dedication to pushing the boundaries of technology have established him as a respected figure in the world of inventors. His relentless pursuit of excellence continues to inspire future generations of innovators.

Profile summary based on public USPTO records.